Latest AI and machine learning research in chemotherapy for healthcare professionals.
Brain cancer is one of the most challenging malignancies and a major contributor to worldwide morbid...
Alopecia areata (AA) is a common autoimmune condition that affects approximately 2% of the global po...
BACKGROUND: Immunotherapy resistance in lung adenocarcinoma (LUAD) remains a critical clinical chall...
The development and validation of prognostic and predictive biomarkers in breast cancer is limited b...
BACKGROUND AND PURPOSE: Artificial intelligence (AI) algorithms have been used to synthesize standar...
BACKGROUND: Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality...
BACKGROUND: Liver enzyme biomarkers are known to contribute to the onset and progression of colorect...
BACKGROUND: The size of tumour-negative regional lymph nodes (LNnegs) may be associated with the hos...
Perioperative nivolumab significantly improved event-free survival (EFS) compared with placebo in pa...
RATIONALE AND OBJECTIVES: Neoadjuvant chemoimmunotherapy (NCIT) has shown promising efficacy in loca...
BACKGROUND: Patients with muscle-invasive bladder cancer (MIBC) have heterogeneous outcomes followin...
BACKGROUND: The tumor microenvironment (TME) in cervical cancer may undergo immunological changes du...
PURPOSE: To evaluate the predictive value of MRI sub-regional radiomics of the gluteus maximus for r...
Despite advances in total mesorectal excision and neoadjuvant therapy, locally recurrent rectal canc...
INTRODUCTION: Infection is a common and potentially fatal complication during the treatment of hemat...
DEGDB, also known as diethylene glycol dibenzoate, is a new eco-conscious plasticizer on the block. ...
Idiopathic inflammatory myopathies (IIM) are heterogeneous immune-mediated diseases characterized by...
BACKGROUND: Large-scale evidence on the role of endoscopy alone as the assessment tool to identify c...
Postoperative nausea and vomiting (PONV) is a frequent and serious complication after surgery. PONV ...
PURPOSE: The clinical outcome of urothelial carcinoma presents significant variability, reflecting i...
BACKGROUND & AIMS: First-line immuno-chemotherapy is standard for advanced biliary tract cancer (BTC...